Bolt Biotherapeutics, Inc.
BOLT· Nasdaq
Released May 12, 2022, after the close
10-Q filed May 12, 2022, 42 days after period end · 0000950170-22-009664
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Revenue | $813.00K | — | $164.00K |
| Net Income | -$23.68M | -$24.45M | -$8.63M |
| EPS Diluted | -$0.64 | -$1.14 | -$4.16 |
Bolt Biotherapeutics, Inc. · CIK 1641281 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.